Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3077-2024Class II

Syringes with Eccentric Tips labeled as: 1) SOL-M 10ml Eccentric Tip Syringe w/o Needle, Model No. P180010ET...

Sol-Millennium Medical, Inc. / initiated 2024-05-09 / Open, Classified

Sol-Millennium Medical Inc. began a recall of Syringes with Eccentric Tips labeled as: 1) SOL-M 10ml Eccentric Tip Syringe w/o Needle, Model No. P180010ET, UPC 81001809551; 2) SOL-M 20ml Eccentric Tip... on . FDA classified it as Class II and gives the reason as "Products in distribution were found by FDA to be to be substantially different from the current cleared 510(k)s with a major change or modification to the device s intended use". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-3077-2024
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Sol-Millennium Medical, Inc.
Product
Syringes with Eccentric Tips labeled as: 1) SOL-M 10ml Eccentric Tip Syringe w/o Needle, Model No. P180010ET, UPC 81001809551; 2) SOL-M 20ml Eccentric Tip Syringe w/o Needle, Model No. P180020ET, UPC 810018098605; 3) SOL-M 60ml Eccentric Tip Syringe w/o Needle, Model No. P180060ET, UPC 810018098698;
Product code
FMF Syringe, Piston
Reason for recall
Products in distribution were found by FDA to be to be substantially different from the current cleared 510(k)s with a major change or modification to the device s intended use.
FDA root cause
Other
Action
Sol M issued a Voluntary Recall Action Letter to Distributors to its consignees on 05/09/2024 via email. The notice explained the reason for the recall and requested the following: "ACTIONS REQUIRED: 1. Examine your inventory and quarantine the affected product codes and lots subject to this recall action. 2. Distributors, please identify your customers, and notify them at once of this recall action to the distributor level. Such notification may be enhanced by including the enclosed letter (Appendix B) for your customers and Healthcare Providers (HCP s) in the field. 3. Return the enclosed Appendix B with the information via email to [email protected]. The quarantine should be carried out to the wholesale and distributor level. Products in the field beyond the control of the distributor or wholesaler should be recalled from the field and returned to the distributor. Distributors should quarantine the products in inventory and quarantine the products received from customers until the 510(k) submissions are pending or cleared. The returned product should be quarantined in a secure location to avoid distribution based on your quality management procedures. We will provide communication with any updates as we work with the FDA."
Distribution
US Nationwide, Czech Republic, Belgium, Portugal, Canada, Saudi Arabia, Netherland, France, Switzerland, Latvia, UK, Spain, Germany, Philippines, Australia, Malaysia, Jamaica, Slovenia, Brazil, Taiwan, Denmark, Sweden, Singapore, Romania, Poland, Barbados, Mexico, Guatemala, Chile, Ireland, Italy, Panama
Product codes and lots
1) Model No. P180010ET, Lot Numbers: 4209010; 2) Model No. P180020ET, Lot Numbers: 4209011; 3) Model No. P180060ET, Lot Numbers: 4209009, 4209011;

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3077-2024
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3074-2024Class IIOngoingVoluntary: Firm initiated
Z-3075-2024Class IIOngoingVoluntary: Firm initiated
Z-3076-2024Class IIOngoingVoluntary: Firm initiated
Z-3077-2024Class IIOngoingVoluntary: Firm initiated
Z-3078-2024Class IIOngoingVoluntary: Firm initiated
Z-3079-2024Class IIOngoingVoluntary: Firm initiated